S. Sarkar

Randomized Placebo-Controlled Trial of Emricasan in Non-alcoholic Steatohepatitis (NASH) Cirrhosis with Severe Portal Hypertension.

J. Chan, P. Thuluvath, J. Bosch, 2019, Journal of hepatology.